Advisor Net Financial, Inc Intercept Pharmaceuticals, Inc. Transaction History

Advisor Net Financial, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 04, 2022	BUY	$12.21 - $19.7 $280 - $453	23 New	23 $0
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $14,282 - $30,900	-249 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$58.69 - $80.46 $26,469 - $36,287	-451 Reduced 64.43%	249 $17,000
Q2 2019 Jul 15, 2019	BUY	$77.77 - $120.68 $54,439 - $84,476	700 New	700 $56,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.